Tuberculosis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 5, 2008, Pages 531-534

  Goodman, Anna ^a   Lipman, Marc ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Drug resistance; Immunosuppression; Interferon gamma release assay tests; Latent tuberculosis infection; Tuberculosis

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; 6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; AMIKACIN; BCG VACCINE; CAPREOMYCIN; CORTICOSTEROID; ETHAMBUTOL; IMMUNOMODULATING AGENT; INFLIXIMAB; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAPENTINE; TNC 207; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMBINATION CHEMOTHERAPY; CROHN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION RATE; MIXED INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID PROBE; PSORIASIS; RHEUMATOID ARTHRITIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; TUBERCULOUS MENINGITIS; UNITED KINGDOM;

EID: 55049123744     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-5-531     Document Type: Article

References (19)

1. Health Protection Agency. Tuberculosis in the UK. Annual report on tuberculosis surveillance and control in the UK 2007. www.hpa.org.uk
2. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350: 2060-7.
3. French CE, Antoine D, Gelb D et al. Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis 2007;11:577-84.
4. Krüüner A, Pehme L, Ghebremichael S et al. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2002;35:146-55.
5. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
6. The National Collaborating Centre for Chronic Conditions at the Royal College of Physicians. Tuberculosis. Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London: Royal College of Physicians, 2006.
7. Breen RA, Leonard O, Perrin FM et al. How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis? Int J Tuberc Lung Dis 2008;12:44-9.
8. Steingart KR, Ng V, Henry M et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6:664-74.
9. Moore DA, Evans CA, Gilman RH et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-50.
10. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
11. Gardam MA, Keystone EC, Menzies R et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003;3:148-55.
12. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Review. Thorax 2005;60: 800-5.
13. Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51.
14. Aziz MA, Wright A, Laszlo A et al; WHO/International Union Against Tuberculosis And Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006;368:2142-54.
15. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80.
16. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007;370:2030-43.
17. Stop TB Partnership. The stop TB strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva: World Health Organization, 2006.
18. Sacchettini JC, Rubin EJ, Freundlich JS. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol 2008;6:41-52.
19. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Review. Lancet Infect Dis 2005;5:361-73.